Novo Nordisk
NVO
804 hedge funds and large institutions have $12.7B invested in Novo Nordisk in 2021 Q3 according to their latest regulatory filings, with 104 funds opening new positions, 282 increasing their positions, 234 reducing their positions, and 27 closing their positions.
285% more first-time investments, than exits
New positions opened: 104 | Existing positions closed: 27
196% more call options, than puts
Call options by funds: $123M | Put options by funds: $41.6M
21% more repeat investments, than reductions
Existing positions increased: 282 | Existing positions reduced: 234
18% more funds holding in top 10
Funds holding in top 10: 11 → 13 (+2)
15% more capital invested
Capital invested by funds: $11B → $12.7B (+$1.68B)
9% more funds holding
Funds holding: 735 → 804 (+69)
0.07% more ownership
Funds ownership: 14.85% → 14.91% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$75.2M |
| 2 |
Two Sigma Advisers
New York
|
+$53.7M |
| 3 |
Goldman Sachs
New York
|
+$38.2M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$37.5M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$33.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$246M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$52.7M |
| 3 |
SRIM
Saratoga Research & Investment Management
Saratoga,
California
|
-$38.9M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$22M |
| 5 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$17.3M |
NVO Hedge Fund Activity: Q3 2021 in Review
804 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2021, worth a combined $12.7B — up 15% from $11B a quarter earlier.
Buyers outnumbered sellers: 104 funds opened new NVO positions and 27 closed out — a net gain of 77 holders — while 282 added to existing stakes and 234 trimmed.
The largest buyer was Millennium Management, adding an estimated $75.2M. The largest seller was Renaissance Technologies, cutting an estimated $246M.
- 804 institutional investors held Novo Nordisk (NVO) as of Q3 2021, up from 735 in Q2 2021.
- Funds reported $12.7B of Novo Nordisk stock for Q3 2021, up 15% quarter-over-quarter.
- 104 funds opened new Novo Nordisk positions in Q3 2021 and 27 closed out, a net change of +77 holders.
- The largest Novo Nordisk buyer in Q3 2021 was Millennium Management, an estimated $75.2M added.
- The largest Novo Nordisk seller in Q3 2021 was Renaissance Technologies, an estimated $246M sold.
Based on aggregated 13F filings for Q3 2021.